btlines

BMX GPW Periodic report · PAP Biznes

BioMaxima SA (BMX) · Q1 2026 results

Share price: 8.52 zł · 2026-11-10

Results Q1 2026 vs Q1 2025 · year over year · published 29 May 2026 and 30 May 2025

Revenue down 7.6% year on year. The language turned more upbeat.

Only a basic analysis is available for this company at the moment.

1 · Numbers

−7.6%

Revenue vs Q1 2025

Revenue 14.1M vs 15.3M

2 · How the report reads

More upbeat

Language tone vs last period

Report language: upbeat for a company report — more upbeat than in Q1 2025.

Weak signal: formal report language, not a call.

3 · What stood out Nothing unusual flagged this period.

Official channels

The company's own website and social media accounts.

Read between the lines

No major shifts flagged this period.

Tone

How upbeat the language was, compared with other companiesiTone counts positive minus negative finance words, adjusted for length. Executives mostly speak positively, so the labels compare each call with every company's latest call: “typical” is the middle third, “very upbeat” the top tenth, “cautious” the bottom tenth.. Dot: Q1 2026. Ring: Q1 2025.

Report language Upbeat (was typical)

Upbeat for a company report — more upbeat than in Q1 2025. Periodic reports carry legally required risk wording, so their tone moves little and is a weak signal.

Sentences that drove the tone
“The further development of the microbiology segment remains particularly significant, the sales of which increased to 8,871 thousand.”
“and reflected as a decrease in equity through an adjustment of prior years' results, and in the case of cash flow from operations – as a decrease in liabilities.”
“PLN the previous year, which represents an increase of over 18% and a further increase in their share of total sales.”

Full figures

PLN · PAP Biznes report (2026-05-29)

Metric Q1 2026 Q1 2025 Change
Revenue 14.1M 15.3M −7.6%
Operating income — 684.0K
Net income — 589.0K
P/E today 330.0 358.7 111.2 +247.5

Topics

Topics are drawn from the full report text, not management commentary.

Most discussed now

  • The table presents the changes in write-downs adjusting the value of receivables during the period covered by the condensed interim…
  • Compared to the previous year, which represents an increase of over 18% and a further increase in their share of total sales.
  • The full consolidation method consists of combining the financial statements of the parent company and subsidiaries by summing, in full…

Faded since Q1 2025

  • Nothing dropped away.

Latest announcements

Official filings, newest first.

Similar companies

Healthcare · Diagnostics & Research
All Healthcare companies →